MARKET

CHE

CHE

Chemed
NYSE

Real-time Quotes | Nasdaq Last Sale

475.52
-2.59
-0.54%
After Hours: 475.52 0 0.00% 18:05 09/17 EDT
OPEN
478.74
PREV CLOSE
478.11
HIGH
479.48
LOW
472.99
VOLUME
233.09K
TURNOVER
--
52 WEEK HIGH
560.00
52 WEEK LOW
417.41
MARKET CAP
7.48B
P/E (TTM)
25.54
1D
5D
1M
3M
1Y
5Y
Chemed (CHE) Moves to Buy: Rationale Behind the Upgrade
Zacks.com · 13h ago
Boston Trust Walden Midcap Fund Buys Chemed Corp, Laboratory Corp of America Holdings, Masco ...
GuruFocus News · 16h ago
Boston Trust Mid Cap Fund Buys Chemed Corp, Masco Corp, Baker Hughes Co, Sells Waters Corp, ...
GuruFocus News · 16h ago
Boston Trust Walden Small Cap Fund Buys Helen Of Troy, Columbia Banking System Inc, Chemed ...
GuruFocus News · 16h ago
Bny Mellon Investment Portfolios Buys The Toro Co, National Retail Properties Inc, Woodward ...
GuruFocus News · 18h ago
Bernstein Fund Inc Buys iShares Russell 2000 ETF, Intellia Therapeutics Inc, CommScope Holding ...
GuruFocus News · 4d ago
Opening Bell, August 30, 2021
Chemed rings the opening bell at the New York Stock Exchange and Reservoir Media rings the opening bell at the Nasdaq.
CNBC.com · 08/30 14:04
Chemed (CHE) Up 1.9% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 08/26 15:31
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CHE. Analyze the recent business situations of Chemed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CHE stock price target is 577.25 with a high estimate of 609.00 and a low estimate of 515.00.
EPS
Institutional Holdings
Institutions: 590
Institutional Holdings: 15.40M
% Owned: 97.88%
Shares Outstanding: 15.73M
TypeInstitutionsShares
Increased
127
624.94K
New
61
248.39K
Decreased
150
1.08M
Sold Out
52
172.53K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.60%
Healthcare Providers & Services
+0.93%
Key Executives
Non-Executive Chairman/Independent Director
George Walsh
President/Chief Executive Officer/Director
Kevin McNamara
Chief Financial Officer/Executive Vice President
David Williams
Executive Vice President
Spencer Lee
Executive Vice President
Nicholas Westfall
Vice President/Controller
Michael Witzeman
Vice President/Secretary
Brian Judkins
Director
Thomas Hutton
Independent Director
Ron DeLyons
Independent Director
Joel Gemunder
Independent Director
Patrick Grace
Independent Director
Christopher Heaney
Independent Director
Andrea Lindell
Independent Director
Thomas Rice
Independent Director
Donald Saunders
Declaration Date
Dividend Per Share
Ex-Div Date
08/06/2021
Dividend USD 0.36
08/13/2021
05/17/2021
Dividend USD 0.34
05/26/2021
02/19/2021
Dividend USD 0.34
02/26/2021
11/06/2020
Dividend USD 0.34
11/13/2020
08/06/2020
Dividend USD 0.34
08/14/2020
05/18/2020
Dividend USD 0.32
05/27/2020
02/21/2020
Dividend USD 0.32
02/28/2020
11/01/2019
Dividend USD 0.32
11/07/2019
08/02/2019
Dividend USD 0.32
08/09/2019
05/20/2019
Dividend USD 0.3
05/29/2019
02/22/2019
Dividend USD 0.3
03/01/2019
11/02/2018
Dividend USD 0.3
11/08/2018
08/03/2018
Dividend USD 0.3
08/10/2018
05/21/2018
Dividend USD 0.28
05/30/2018
02/16/2018
Dividend USD 0.28
02/23/2018
11/03/2017
Dividend USD 0.28
11/10/2017
08/07/2017
Dividend USD 0.28
08/10/2017
05/15/2017
Dividend USD 0.26
05/23/2017
02/17/2017
Dividend USD 0.26
02/23/2017
11/04/2016
Dividend USD 0.26
11/09/2016
About CHE
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Webull offers kinds of Chemed Corporation stock information, including NYSE:CHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHE stock methods without spending real money on the virtual paper trading platform.